Increasing preference for outsourcing of HPAPI manufacturing and rich pipeline with targeted therapeutic drugs would drive market growth The global high potency active pharmaceutical ingredients (HPAPI) market size is expected to reach USD 32.11 Billion in 2028 registering a CAGR of 9.1% over the forecast period, according to a latest report by Reports and Data. Major...